Search

Your search keyword '"Thrombospondins therapeutic use"' showing total 25 results

Search Constraints

Start Over You searched for: Descriptor "Thrombospondins therapeutic use" Remove constraint Descriptor: "Thrombospondins therapeutic use" Language english Remove constraint Language: english
25 results on '"Thrombospondins therapeutic use"'

Search Results

1. Serum thrombospondin-2 level changes with liver stiffness improvement in patients with type 2 diabetes.

2. Thrombospondin-1 is an endogenous substrate of cereblon responsible for immunomodulatory drug-induced thromboembolism.

3. Thrombospondin-1, CD47, and SIRPα display cell-specific molecular signatures in human islets and pancreata.

4. Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma.

5. Salinomycin alleviates osteoarthritis progression via inhibiting Wnt/β-catenin signaling.

6. Polydatin inhibits IL-1β-mediated chondrocyte inflammation and ameliorates cartilage degradation: Involvement of the NF-κB and Wnt/β-catenin pathways.

7. Melatonin Prevents Chondrocyte Matrix Degradation in Rats with Experimentally Induced Osteoarthritis by Inhibiting Nuclear Factor-κB via SIRT1.

8. Thrombospondin 2 is a Functional Predictive and Prognostic Biomarker for Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy.

9. Tissue-targeted R-spondin mimetics for liver regeneration.

10. Therapeutic Role for TSP-2 Antibody in a Murine Asthma Model.

11. R-Spondin1 expands Paneth cells and prevents dysbiosis induced by graft-versus-host disease.

12. Management of Mucositis During Chemotherapy: From Pathophysiology to Pragmatic Therapeutics.

13. Thrombospondin promoted anti-tumor of adenovirus-mediated calreticulin in breast cancer: Relationship with anti-CD47.

14. Thrombospondin-2 secreted by human umbilical cord blood-derived mesenchymal stem cells promotes chondrogenic differentiation.

15. Improved therapeutic responses for liposomal doxorubicin targeted via thrombospondin peptidomimetics versus untargeted doxorubicin.

16. Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatments.

17. Thrombospondins.

18. Thrombospondin-based antiangiogenic therapy.

19. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.

20. Inducing intestinal growth.

21. Thrombospondin modules and angiogenesis.

22. Tumor progression: the effects of thrombospondin-1 and -2.

23. Angiogenesis: prognostic and therapeutic implications in gynecologic and breast malignancies.

24. Thrombospondins as anti-angiogenic therapeutic agents.

25. Anti-angiogenic treatment strategies for malignant brain tumors.

Catalog

Books, media, physical & digital resources